Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Oncology | Hepatology (Liver, Pancreatic, Gall Bladder)

Digestive System Neoplasms Clinical Trials

A listing of Digestive System Neoplasms medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 Last 

Arizona

Mayo Clinic Arizona
Phoenix Arizona 85054

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Virginia G. Piper Cancer Center at Scottsdale Healthcare
Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

California

University of California San Francisco
San Francisco California 94115
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Connecticut

Yale Cancer Center
New Haven Connecticut 06519

A clinical trial to evaluate treatments using Sorafenib, Capecitabine for patients with Metastatic Breast Cancer or Gastrointestinal Tumors

District of Columbia

DC Endoscopy Center
Washington District of Columbia 20006

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Florida

Lynn Cancer Institute
Boca Raton Florida 33486
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Florida Cancer Specialists
Fort Myers Florida 33916
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

University of Florida
Gainesville Florida 32610
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

University of Miami
Miami Florida 33136

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Florida Hospital Cancer Institute Memorial System
Orlando Florida 32804
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

View More »

Florida Cancer Specialists
St. Petersburg Florida 33705
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Illinois

Illinois Cancer Specialists
Arlington Heights Illinois 60005
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rush University Medical Center
Chicago Illinois 60612

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

University of Chicago Medicine
Chicago Illinois 60637

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

NorthShore University Health System
Evanston Illinois 60201

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Northshore University Healthsystem Research Institute
Evanston Illinois 60201
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Louisiana

Gastroenterology Associates, LLC
Baton Rouge Louisiana 70809

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Maryland

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore Maryland 21205

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Chevy Chase Endoscopy Center
Chevy Chase Maryland 20815

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

MGG Group, Co. Inc./Chevy Chase Clinical Research
Chevy Chase Maryland 20815

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Michigan

University of Michigan
Ann Arbor Michigan 48109
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Karmanos Cancer Institute
Detroit Michigan 48201
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Detroit Clinical Research Center, PC
Farmington Hills Michigan 48334

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Minnesota

University of Minnesota Masonic Cancer Clinic
Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

Mayo Clinic
Rochester Minnesota 55905

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Missouri

Center for Digestive and Liver Diseases, Inc
Mexico Missouri 65265

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Nebraska

Methodist Cancer Center
Omaha Nebraska 68114
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New Jersey

Saint Barnabas Medical Center
Livingston New Jersey 07039
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

New York

Memorial Sloan-Kettering Cancer Center
New York New York 10065

A clinical research study of TAS-102 and CPT-11 for the treatment of Advanced Gastrointestinal Tumors

Mount Sinai School of Medicine
New York New York 10029

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Columbia University Medical Center
New York New York 10032
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

University of Rochester Medical Center
Rochester New York 14642
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

North Carolina

Asheville Gastroeneterology Associates
Asheville North Carolina 28801

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Ohio

Oncology Hematology Care Inc.
Cincinnati Ohio 45242
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Ohio State University Comprehensive Cancer Center
Columbus Ohio 43210
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Oregon

Oregon Health and Sciences University
Portland Oregon 97239
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pennsylvania

University of Pennsylvania
Philadelphia Pennsylvania 19104

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Tennessee

Tennessee Oncology - Chattanooga
Chattanooga Tennessee 37404
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Tennessee Oncology PLLC
Nashville Tennessee 37203
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Vanderbilt University Medical Center
Nashville Tennessee 37232
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Texas

UT Southwestern Medical Center
Dallas Texas 75390
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Center for Cancer and Blood Disorders
Fort Worth Texas 76104
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Virginia

Blue Ridge Medical Research
Lynchburg Virginia 24502

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Washington

Swedish Medical Center Cancer Institute
Seattle Washington 98104

A clinical research study of AUY922 and Cetuximab

Virginia Mason Medical Center
Seattle Washington 98101
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Seattle Cancer Care Alliance
Seattle Washington 98109
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Wisconsin

University of Wisconsin Hospital and Clinics
Madison Wisconsin 53792

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Wisconsin Center for Advanced Research
Milwaukee Wisconsin 53215

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Australia

Monash Medical Centre Moorabbin Campus
Bentleigh East Victoria 3165
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

The Canberra Hospital
Garran Australian Capital Territory 2605
Updated

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

First 1 2 Last